Why is it prescribed?
Ivacaftor is used for the treatment of cystic fibrosis (CF):
- in children age 12 months and older who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R
- also indicated for the treatment of cystic fibrosis (CF) in patients age 18 years and older with an R117H mutation in the CFTR gene.
See other drugs used in the treatment of •
Contact your doctor if any of these side effects persists or are bothersome:
• Stomach (abdominal) pain
• Common cold
• Runny nose
• Upper respiratory tract infection
• Changes in the type of bacteria in your sputum
• Nasal congestion
• Sinus congestion
• Sore throat
• Joint pain
Various mutations of the cystic fibrosis gene block the "gates" that allow the flow of salt across the cell membranes. This causes mucus to become thick and clog the lungs. Ivacaftor is a "cystic fibrosis transmembrane conductance regulator (CFTC) potentiator". The CFTR protein is a channel at the surface of the cells that allows the movement of particles such as chloride in and out of the cell, contributing to salt and water balance. Ivacaftor helps this CFTR protein channel or "open the gates" more often allowing more salt to pass through. The thick mucus is reduced and cystic fibrosis symptoms lessen.
Use with caution if you:
- have kidney or liver problems
- have cataracts
Possible drug interactions:
- ketoconazole, itraconazole, posaconazole, voriconazole, fluconazole
- some antibiotics such as clarithromycin, erythromycin, rifampin, rifabutin
- phenobarbital, carbamazepine, phenytoin
- midazolam, alprazolam, diazepam, triazolam
- cyclosporine, tacrolimus
- St. John’s wort
Use in pregnancy and breastfeeding. Little is known about the safety of this medication when used in pregnancy and breastfeeding. Consult your doctor or pharmacist before use.